Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
<< Back to Results
The main purpose of this study is to gather information about a new oral anticoagulant that has been approved for in certain patients with atrial fibrillation and is not evaluated in patients after TAVI (Transcatheter Aortic Valve Implantation) that may help to treat your disease.
Location:
Essentia Health Duluth
Disclosures:
None
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.
